Dr Malik was one of the investigators for the ORBITA trial published in the Lancet, presented at TCT 2017 in Denver earlier this month, and discussed in this video.
Angioplasty and stenting in heart attacks saves lives. In patients with stable symptoms and one blockage only, medical therapy is also very good. The ORBITA trial really breaks new ground in challenging the “see it, stent it” occluostenotic reflex that come in cardiology have had.